Trials / Conditions / Congenital Cytomegalovirus Infection

Congenital Cytomegalovirus Infection

15 registered clinical trials studyying Congenital Cytomegalovirus Infection — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus NCT06118515	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Terminated	Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssio NCT05170269	Biotest	Phase 3
Terminated	Asymptomatic Congenital CMV Treatment NCT03301415	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk NCT05754879	Central Hospital, Nancy, France	—
Unknown	Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy NCT03973359	Fondazione IRCCS Policlinico San Matteo di Pavia	N/A
Completed	Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV NCT02782988	Institut Pasteur	—
Completed	Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregn NCT02351102	Rabin Medical Center	Phase 2 / Phase 3
Withdrawn	Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine NCT02594566	Virginia Commonwealth University	Phase 1
Completed	A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China NCT02645396	Jun Zhang	—
Completed	A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China NCT02710864	Jun Zhang	—
Completed	Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening NCT02139423	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Congenital Cytomegalovirus: Efficacy of Antiviral Treatment NCT02005822	Dr. Ann C.T.M. Vossen	Phase 3
Completed	Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cy NCT01923636	Assistance Publique - Hôpitaux de Paris	N/A
Terminated	Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial NCT01655212	Dr. Ann C.T.M. Vossen	Phase 3
Completed	A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) NCT01376778	The George Washington University Biostatistics Center	Phase 3